Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Umbilical cord blood transplantation for non-malignant diseases

Abstract

Many factors, including lower risk of GVHD, rapid availability of 4/6–6/6 matched cord blood (CB) units and incremental gains in the outcomes, have led to an increasing use of CB transplantation (CBT) to treat many patients who lack fully matched adult BM donors. A large electronically searchable worldwide inventory of publicly banked CB units allows for quicker donor identification and selection. In this review, we examine the current status and cumulative experience of related and unrelated donor CBT for the treatment of non-malignant diseases, including hemoglobinopathies, BM failure syndromes, primary immunodeficiency diseases (PIDs) and inherited metabolic disorders (IMDs), and conclude that CBT offers a promising and effective therapy for these diseases. Future strategies to facilitate earlier diagnosis and to decrease transplant-related risks should further improve the short- and long-term outcomes. Every effort should be made to perform transplantation early in the course of disease before extensive damage to various tissues and organs ensues.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947–1954.

    Article  Google Scholar 

  2. Kurtzberg J, Prasad VK, Carter SL, Wagner JE, Baxter-Lowe LA, Wall D et al. Results of the cord blood transplantation study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood 2008; 112: 4318–4327.

    Article  CAS  Google Scholar 

  3. Martin PL, Carter SL, Kernan NA, Sahdev I, Wall D, Pietryga D et al. Results of the cord blood transplantation study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases. Biol Blood Marrow Transplant 2006; 12: 184–194.

    Article  Google Scholar 

  4. Prasad VK, Mendizabal A, Parikh SH, Szabolcs P, Driscoll TA, Page K et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood 2008; 112: 2979–2989.

    Article  CAS  Google Scholar 

  5. Rocha V, Wagner Jr JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000; 342: 1846–1854.

    Article  CAS  Google Scholar 

  6. Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.

    Article  CAS  Google Scholar 

  7. Rocha V, Sanz G, Gluckman E . Umbilical cord blood transplantation. Curr Opin Hemat 2004; 11: 375–385.

    Article  Google Scholar 

  8. Rocha V, Gluckman E . Clinical use of umbilical cord blood hematopoietic stem cells. Biol Blood Marrow Transplant 2006; 12: 34–41.

    Article  Google Scholar 

  9. Rubinstein P, Carrier C, Scaradavou A, Kurtzberg J, Adamson J, Migliaccio AR et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 1998; 339: 1565–1577.

    Article  CAS  Google Scholar 

  10. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 2002; 100: 1611–1618.

    CAS  PubMed  Google Scholar 

  11. Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.

    Article  CAS  Google Scholar 

  12. Kurtzberg J, Graham M, Casey J, Olson J, Stevens CE, Rubinstein P . The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. Blood Cells 1994; 20: 275–283.

    CAS  PubMed  Google Scholar 

  13. Barker JN, Davies SM, Defor T, Ramsay NK, Weisdorf DJ, Wagner JE . Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 2001; 97: 2957–2961.

    Article  CAS  Google Scholar 

  14. Barker JN, Wagner JE . Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol Hematol 2003; 48: 35–43.

    Article  Google Scholar 

  15. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993; 329: 840–844.

    Article  CAS  Google Scholar 

  16. Boulad F, Giardina P, Gillio A, Kernan N, Small T, Brochstein J et al. Bone marrow transplantation for homozygous beta-thalassemia. The Memorial Sloan-Kettering Cancer Center experience. Ann N Y Acad Sci 1998; 850: 498–502.

    Article  CAS  Google Scholar 

  17. Chandy M, Balasubramanian P, Ramachandran SV, Mathews V, George B, Dennison D et al. Randomized trial of two different conditioning regimens for bone marrow transplantation in thalassemia--the role of busulfan pharmacokinetics in determining outcome. Bone Marrow Transplant 2005; 36: 839–845.

    Article  CAS  Google Scholar 

  18. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med 1990; 322: 417–421.

    Article  CAS  Google Scholar 

  19. Lucarelli G, Andreani M, Angelucci E . The cure of thalassemia by bone marrow transplantation. Blood Rev 2002; 16: 81–85.

    Article  CAS  Google Scholar 

  20. Bernaudin F, Socie G, Kuentz M, Chevret S, Duval M, Bertrand Y et al. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. Blood 2007; 110: 2749–2756.

    Article  CAS  Google Scholar 

  21. Vermylen C, Cornu G, Ferster A, Brichard B, Ninane J, Ferrant A et al. Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplant 1998; 22: 1–6.

    Article  CAS  Google Scholar 

  22. Walters MC, Patience M, Leisenring W, Eckman JR, Scott JP, Mentzer WC et al. Bone marrow transplantation for sickle cell disease. N Engl J Med 1996; 335: 369–376.

    Article  CAS  Google Scholar 

  23. Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. Blood 2000; 95: 1918–1924.

    CAS  PubMed  Google Scholar 

  24. Bhatia M, Walters MC . Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future. [Review] [57 references]. Bone Marrow Transplant 2008; 41: 109–117.

    Article  CAS  Google Scholar 

  25. Issaragrisil S, Visuthisakchai S, Suvatte V, Tanphaichitr VS, Chandanayingyong D, Schreiner T et al. Brief report: transplantation of cord-blood stem cells into a patient with severe thalassemia. N Engl J Med 1995; 332: 367–369.

    Article  CAS  Google Scholar 

  26. Reed W, Walters M, Lubin BH . Collection of sibling donor cord blood for children with thalassemia. J Pediatr Hematol Oncol 2000; 22: 602–604.

    Article  CAS  Google Scholar 

  27. Walters MC, Quirolo L, Trachtenberg ET, Edwards S, Hale L, Lee J et al. Sibling donor cord blood transplantation for thalassemia major: experience of the sibling donor cord blood program. Ann N Y Acad Sci 2005; 1054: 206–213.

    Article  Google Scholar 

  28. Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S et al. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood 2003; 101: 2137–2143.

    Article  CAS  Google Scholar 

  29. Fang J, Huang S, Chen C, Zhou D, Li CK, Li Y et al. Umbilical cord blood transplantation in Chinese children with beta-thalassemia. J Pediatr Hematol Oncol 2004; 26: 185–189.

    Article  Google Scholar 

  30. Brichard B, Vermylen C, Ninane J, Cornu G . Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia. J Pediatr 1996; 128: 241–243.

    Article  CAS  Google Scholar 

  31. Gore L, Lane PA, Quinones RR, Giller RH . Successful cord blood transplantation for sickle cell anemia from a sibling who is human leukocyte antigen-identical: implications for comprehensive care. J Pediatr Hematol Oncol 2000; 22: 437–440.

    Article  CAS  Google Scholar 

  32. Hall JG, Martin PL, Wood S, Kurtzberg J . Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol 2004; 26: 382–385.

    Article  Google Scholar 

  33. Adamkiewicz TV, Szabolcs P, Haight A, Baker KS, Staba S, Kedar A et al. Unrelated cord blood transplantation in children with sickle cell disease: review of four-center experience. Pediatr Transplant 2007; 11: 641–644.

    Article  CAS  Google Scholar 

  34. Fang J, Huang S, Chen C, Zhou D . Unrelated umbilical cord blood transplant for beta-thalassemia major. J Trop Pediatr 2003; 49: 71–73.

    Article  Google Scholar 

  35. Jaing TH, Hung IJ, Yang CP, Lin TY, Chow R, Hsieh SI . Successful unrelated cord blood transplantation in a child with beta-thalassemia major. J Trop Pediatr 2005; 51: 122–124.

    Article  Google Scholar 

  36. Jaing TH, Yang CP, Hung IJ, Chen SH, Sun CF, Chow R . Transplantation of unrelated donor umbilical cord blood utilizing double-unit grafts for five teenagers with transfusion-dependent thalassemia. Bone Marrow Transplant 2007; 40: 307–311.

    Article  Google Scholar 

  37. Mazur M, Kurtzberg J, Halperin E, Ciocci G, Szabolcs P . Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning. J Pediatr Hematol Oncol 2006; 28: 840–844.

    Article  CAS  Google Scholar 

  38. Vanichsetakul P, Wacharaprechanont T, Charoen R, Seksarn P, Kupatawintu P . Umbilical cord blood transplantation in children with beta-thalassemia diseases. J Med Assoc Thai 2004; 87: S62–S67.

    PubMed  Google Scholar 

  39. Tan PH, Hwang WY, Goh YT, Tan PL, Koh LP, Tan CH et al. Unrelated peripheral blood and cord blood hematopoietic stem cell transplants for thalassemia major. Am J Hematol 2004; 75: 209–212.

    Article  Google Scholar 

  40. Jaing TH, Hung IJ, Yang CP, Chen SH, Sun CF, Chow R . Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major. Biology of Blood and Marrow Transplantation 2005; 11: 349–353.

    Article  Google Scholar 

  41. Jaing TH, Wang B, Gjertson D, Petz L, Chow R . Unrelated cord blood transplantation (UCBT) of 30 consecutive patients with transfusion-dependent [beta]-thalassemia from a single center. Biol Blood Marrow Transplant 2009; 15: 24–25.

    Article  Google Scholar 

  42. Bhatia M, Morris E, Moore V, Tallamy B, George D, Garvin JH et al. A pilot study of reduced intensity conditioning (RI) with busulfan (Bu), fludarabine (Flu), and alemtuzumab followed by allogeneic stem cell transplantation (alloSCT) to induce sustained mixed donor chimerism in patients with symptomatic sickle cell disease (SCD). Biol Blood Marrow Transplant 2009; 15: 23–24.

    Article  Google Scholar 

  43. Shenoy S, Grossman WJ, DiPersio J, Yu LC, Wilson D, Barnes YJ et al. A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders. Bone Marrow Transplant 2005; 35: 345–352.

    Article  CAS  Google Scholar 

  44. Buckley RH, Schiff SE, Schiff RI, Roberts JL, Markert ML, Peters W et al. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. Semin Hematol 1993; 30: 92–101.

    CAS  PubMed  Google Scholar 

  45. Cairo MS, Rocha V, Gluckman E, Hale G, Wagner J . Alternative allogeneic donor sources for transplantation for childhood diseases: unrelated cord blood and haploidentical family donors. Biol Blood Marrow Transplant 2008; 14: 44–53.

    Article  Google Scholar 

  46. Parikh SH, Szabolcs P, Prasad VK, Lakshminarayanan S, Martin PL, Driscoll TA et al. Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation. Pediatr Blood Cancer 2007; 49: 982–984.

    Article  Google Scholar 

  47. Sun JM, Driscoll T, Prasad VK, Parikh S, Szabolcs P, Kurtzberg J et al. Unrelated umbilical cord blood transplantation is an effective therapy for Wiskott-Aldrich syndrome. Biol Blood Marrow Transplant 2009; 15: 76.

    Article  CAS  Google Scholar 

  48. Gluckman E, Rocha V, Ionescu I, Bierings M, Harris RE, Wagner J et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant 2007; 13: 1073–1082.

    Article  Google Scholar 

  49. Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256–2262.

    Article  CAS  Google Scholar 

  50. Neudorf SM, Blatt J, Corey S, Koehler M, Wollman M, Rosner G et al. Graft failure after an umbilical cord blood transplant in a patient with severe aplastic anemia. Blood 1995; 85: 2991–2992.

    CAS  PubMed  Google Scholar 

  51. Yoshimi A, Kojima S, Taniguchi S, Hara J, Matsui T, Takahashi Y et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant 2008; 14: 1057–1063.

    Article  CAS  Google Scholar 

  52. Chan KW, McDonald L, Lim D, Grimley MS, Grayson G, Wall DA . Unrelated cord blood transplantation in children with idiopathic severe aplastic anemia. Bone Marrow Transplant 2008; 42: 589–595.

    Article  CAS  Google Scholar 

  53. Mao P, Zhu Z, Wang H, Wang S, Mo W, Ying Y et al. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol 2005; 75: 430–435.

    Article  CAS  Google Scholar 

  54. Ohga S, Ichino K, Goto K, Hattori S, Nomura A, Takada H et al. Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. Pediatr Transplant 2006; 10: 497–500.

    Article  Google Scholar 

  55. Krivit W . Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases. [Review] [55 references]. Springer Semin Immunopathol 2004; 26: 119–132.

    Article  Google Scholar 

  56. Muenzer J, Fisher A . Advances in the treatment of mucopolysaccharidosis type I. [comment]. N Engl J Med 2004; 350: 1932–1934.

    Article  CAS  Google Scholar 

  57. Fratantoni JC, Hall CW, Neufeld EF . Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science 1968; 162: 570–572.

    Article  CAS  Google Scholar 

  58. Neufeld EF, Fratantoni JC . Inborn errors of mucopolysaccharide metabolism. Science 1970; 169: 141–146.

    Article  CAS  Google Scholar 

  59. Chua SJ, Bielecki R, Wong CJ, Yamanaka N, Rogers IM, Casper RF . Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder-free cell culture. Biochem Biophys Res Commun 2009; 379: 217–221.

    Article  CAS  Google Scholar 

  60. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004; 200: 123–135.

    Article  Google Scholar 

  61. Tracy E, Aldrink J, Panosian J, Beam D, Thacker J, Reese M et al. Isolation of oligodendrocyte-like cells from human umbilical cord blood. Cytotherapy 2008; 10: 518–525.

    Article  CAS  Google Scholar 

  62. Hess DA, Craft TP, Wirthlin L, Hohm S, Zhou P, Eades WC et al. Widespread nonhematopoietic tissue distribution by transplanted human progenitor cells with high aldehyde dehydrogenase activity. Stem Cells 2008; 26: 611–620.

    Article  Google Scholar 

  63. Yagi T, Matsuda J, Tominaga K, Suzuki K, Suzuki K . Hematopoietic cell transplantation ameliorates clinical phenotype and progression of the CNS pathology in the mouse model of late onset Krabbe disease. J Neuropathol Exp Neurol 2005; 64: 565–575.

    Article  Google Scholar 

  64. Kurtzberg J, Kosaras B, Stephens C, Snyder EY . Umbilical cord blood cells engraft and differentiate in neural tissues after human transplantation. Biol Blood Marrow Transplant 2003; 9: 128–129.

    Article  Google Scholar 

  65. Boelens JJ, Wynn RF, O'Meara A, Veys P, Bertrand Y, Souillet G et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225–233.

    Article  CAS  Google Scholar 

  66. Tokimasa S, Ohta H, Takizawa S, Kusuki S, Hashii Y, Sakai N et al. Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: single-institute experience. Pediatr Transplant 2008; 12: 672–676.

    Article  CAS  Google Scholar 

  67. Beam D, Poe MD, Provenzale JM, Szabolcs P, Martin PL, Prasad V et al. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. Biol Blood Marrow Transplant 2007; 13: 665–674.

    Article  Google Scholar 

  68. Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease.[see comment]. N Engl J Med 2005; 352: 2069–2081.

    Article  CAS  Google Scholar 

  69. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.[see comment]. N Engl J Med 2004; 350: 1960–1969.

    Article  CAS  Google Scholar 

  70. Hansen MD, Filipovich AH, Davies SM, Mehta P, Bleesing J, Jodele S et al. Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 2008; 41: 349–353.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V K Prasad.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prasad, V., Kurtzberg, J. Umbilical cord blood transplantation for non-malignant diseases. Bone Marrow Transplant 44, 643–651 (2009). https://doi.org/10.1038/bmt.2009.290

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2009.290

Keywords

This article is cited by

Search

Quick links